REFERENCES
- V. Barillaro, P. Bertholet, S. Henry de Hassonville, E. Ziemon, B. Evrard, L. Delattre, and G. Piel. (2004). Effect of acidic ternary compounds on the formation of miconazole/cyclodextrin inclusion complexes by means of supercritical carbon dioxide. J. Pharm. Pharm. Sci. 30:378–388.
- V. Barillaro, G. Dive, P. Bertholet, B. Evrard, L. Delattre, Z. Eric, and G. Piel. (2007). Theoretical and experimental investigations on miconazole/cyclodextrin/acid complexes: molecular modeling studies. Int. J. Pharm. 342:152–160.
- J. L. Ferrero, B. A. Bopp, K. C. Marsh, S. C. Quigley, M. J. Johnson, D. J. Anderson, J. E. Lamm, K. G. Tolman, S. W. Sanders, and J. H. Cavanaugh. (1990). Metabolism and disposition of clarithromycin in man. Drug Metab. Dispos. 18:441–446.
- H. D. Langtry, and R. N. Brogden. (1997). Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients. Drugs 53:973–1004.
- F. E. Lerner, G. Caliendo, V. Santagade, G. S. M. Santana, M. E. A. Moraes, and G. De Nucci. (2000). Clarithromycin bioequivalence study of two oral formulation in healthy human volunteers. Int. J. Clin. Pharmacol. Ther. 38:345–354.
- M. M. Maitre, M. R. Longhi, and G. G. Granero. (2007). Ternary complexes of flurbiprofen with HP-beta-CD and ethanolamines characterization and transdermal delivery. Drug Dev. Ind. Pharm. 33:311–326.
- Y. Nakagawa, S. Itai, T. Yoshida, and T. Nafai. (1992). Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin. Chem. Pharm. Bull. 40:725–728.
- M. Piette, B. Evrarda, F. Frankenneb, P. Chiapc, P. Bertholeta, D. Castagnea, J. M. Foidartb, L. Delattrea, and G. Piel. (2006). Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28–2653) after IV and oral administration of cyclodextrin solutions. Eur. J. Pharm. Sci. 28:189–195.
- E. Redenti, L. Szente, and J. Szejtli. (2001). Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications. J. Pharm. Sci. 90:979–986.
- E. Redenti, L. Szente, and J. Szejtli. (2000). Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications. J. Pharm. Sci. 89 (1):1–8.
- I. I. Salem, and N. Duzgunes. (2003). Efficacies of cyclodextrin-complexed and liposome-encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages. Int. J. Pharm. 250:403–414.
- V. P Shah, K. K. Midha, and J. W. Findlay. (2000). Bioanalytical method validation−a revisit with a decade of progress. Pharm. Res. 17:1551–1557.
- X. R. Zhang, Y. F. Zhang, D. F. Zhong, Y. Chen, and S. M. Li. (2007). Investigation and physicochemical characterization of clarithromycin−citric acid−cyclodextrins ternary complexes. Drug Dev. Ind. Pharm. 33:1–9.
- R. Zhou, P. Moench, C. Heran, and C. Heran. (2005). pH−Dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a cannie model. Pharm. Res. 22:188–192.